ICON Public Limited Company (ICLR)

ICON Public Limited Company (ICLR) is a healthcare company (diagnostics & research) based in Ireland. The share price is $194.15, up 1.44% on the day, which values the company at $14.55B. Price as of 17 Nov 2026, 17:15 UTC, from Yahoo Finance.

Key facts

Share price
$194.15+1.44% today
Market value
$14.55B
P/E ratio
77.7×last 12 months
Forward P/E
16.7×
Funk Score
55/100
Against its own history
Below its usual priceusual price $222.63
200-week average
$213.269% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

ICON Public Limited Company in more detail

ICLR trades at 77.7× its last twelve months' earnings, 16.7× next year's expected earnings, 1.8× sales. Measured against its own history, the price is 13% below what its usual multiples would imply ($222.63) — below its usual price. It sits 9% below its 200-week average of $213.26.

Over the last five fiscal years ICON Public Limited Company has compounded revenue 24.2% a year, earnings per share -15.1% a year, free cash flow 10.3% a year. Its Funk Score is 55 out of 100 (financial strength 4.0, profitability 6.1, growth 5.5, value 6.2, each out of 10).

In its favour: Five straight years of revenue growth.

13 of the superinvestors tracked here hold ICLR, including Glenn Greenberg (11.2% of the portfolio), Edgar Wachenheim (6.6% of the portfolio), Sequoia Fund team (5.6% of the portfolio).

Superinvestors holding ICLR

13 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:ICLR vs JAZZ (ICON Public Limited Company vs Jazz Pharmaceuticals)ICLR vs SOLV (ICON Public Limited Company vs Solventum)ICLR vs BBIO (ICON Public Limited Company vs BridgeBio Pharma)ICLR vs ASND (ICON Public Limited Company vs Ascendis Pharma)ICLR vs NBIX (ICON Public Limited Company vs Neurocrine Biosciences)

All health care companies by market valueLargest companies in IrelandAll stocks A–Z

ICON Public Limited Company (ICLR): questions and answers

What is ICLR's P/E ratio?

ICON Public Limited Company trades at 77.7× its last twelve months' earnings and 16.7× next year's expected earnings. At its fiscal year-ends over the past 18 years the P/E ranged from 13.8× to 137.6×, with a median of 23.3×.

What is ICLR's PEG ratio?

ICON Public Limited Company's PEG ratio is 0.54 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is ICON Public Limited Company's market cap?

ICON Public Limited Company is valued at $14.55B at a share price of $194.15.

Is ICLR overvalued or undervalued?

Against its own history, ICLR is below its usual price: the price is 13% below the $222.63 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is ICLR above its 200-week moving average?

No. ICLR is 9.0% below its 200-week average of $213.26. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is ICON Public Limited Company growing?

Over the last five fiscal years ICON Public Limited Company's revenue grew 24.2% a year and its earnings per share -15.1% a year; over ten years revenue grew 18.0% a year.

Cite this page

Funkfolio, “ICON Public Limited Company (ICLR) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ICLR

Underlying data: Yahoo Finance; company filings with the SEC.